03880.HK
Medtide Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 20.72
−1.80%Aug 27, 2026, 08:44 UTC
Tide Pharmaceutical (03880.HK) reported interim results for the six months ended June 2026, with revenue of RMB 235 million, down 7.6% year-on-year, and net profit of RMB 53.68 million, down 47.4% year-on-year.
Source: